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DNA methylationAbstract The genomes are regularly targeted by epigenetic regulatory mechanisms (DNA methyl-
ation, histone modiﬁcations, binding of regulatory proteins) in infected cells. In addition, proteins
encoded by microbial genomes may disturb the action of a set of cellular promoters by interacting
with the same epi-regulatory machinery. The outcome of this may result in epigenetic dysregulation
and subsequent cellular dysfunctions that may manifest in or contribute to the development of
pathological changes. How epigenetic methylation decorations on DNA and histones are started
and established remains largely unknown. The inherited nature of these processes in regulation
of genes suggests that they could play key roles in chronic diseases associated with microbial per-
sistence; they might also explain so-called hit-and-run phenomena in infectious disease pathogene-
sis. Microbes infecting mammals may cause diseases by causing hyper-methylation of key cellular
promoters at CpG di-nucleotides and may induce pathological changes by epigenetic reprogram-
ming of host cells they are interacting with elucidation of the epigenetic consequences of
microbe–host interactions may have important therapeutic implications because epigenetic pro-
cesses can be reverted and elimination of microbes inducing patho-epigenetic changes may prevent
disease development.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.Contents
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Epigenetics has been deﬁned as the study of stable alterations
in gene expression potentials that arise during development
and cell proliferation (Jaenisch et al., 2003), or alterations in
DNA function without alterations in DNA sequence (Jones
and Takai, 2001). In 1942, Waddington ﬁrst introduced the
concept of epigenetics (Waddington, 1942) by describing the
inﬂuence of environmental factors on the development of spe-
ciﬁc traits through gene-environment interaction. Wadding-
ton’s words ‘‘the interaction of genes with their environment,
which bring the phenotype into being’’ are the key to develop-
mental biology, i.e. the ‘‘idea that phenotype, or the morpho-
logic and functional properties of an organism, arise
sequentially under a program deﬁned by the genome under
the inﬂuence of the organism’s environment’’ (Van Spe-
ybroeckm, 2002). Modern aspects of epigenetics refer to the
modiﬁcation of DNA and/or related proteins without varia-
tion in nucleotide sequences, which passes the contained infor-
mation to next generation (Fig. 1). It has been thought that
diseases are mainly driven by acquired genetic changes. Now,
it is becoming clear that any phenotype is the result of complex
interactions between genotype, epi-genome, and environment.
Epigenetics focuses on processes that regulate how and when
certain genes are turned on and/or off, while epi-genomics ana-
lyzes epigenetic changes across many genes in a cell or entire
organism. For decades epigenetics is considered to be at the
epicenter of modern medicine since it helps to explain the rela-
tionship between individual genotype and the environment
during all stages of living beings and perturbations in epige-
netic mechanisms that can result in various health disturbances
(Feinberg, 2008). Epi-genomic reprogramming of cell genome
and post-translation modiﬁcation of gene expression are essen-Figure 1 The ﬁgure shows a representative region of genomic DNA.
Methylation of certain genomic regions is inherited (imprinting) and i
acquired (e.g. in cancer cells). The region contains repeat-rich, hype
suppressor gene associated with a hypo-methylated CpG island (indictial mechanisms of the development, regeneration, and postna-
tal life of higher organisms (Choudhary et al., 2009; Tollefsbol,
2010). Human epigenetics may explain some features of vari-
ous monogenic and multifactorial disorders as well as their late
onset, gender effects, ﬂuctuation of symptoms, phenotypic dif-
ferences between monozygotic twins and others. Epigenetic
code can be individual as well as tissue- and cell-speciﬁc and
may change over time because of aging, disease, or environ-
mental factors and other agents. Epigenetics does not involve
an alteration in the nucleotide sequence of the DNA; epige-
nomic effects are connected with the covalent attachment of
different chemical groups to DNA, chromatin, histones, and
other associated proteins during post-translation period.
DNA and histone methylation, acetylation, biotinylation,
phosphorylation, ADP-ribosylation, repeat-induced gene
silencing, miRNA interferences, ubiquitination, sumoylation,
genomic imprinting, and so on are few examples of epigenetics.
Epigenetic DNA and chromatin alterations persist from one
cell division to the next and can occur for several cell genera-
tions (Feinberg, 2008; Tollefsbol, 2010; Furrow et al., 2011). In
body ﬂuids methylated DNA, acetylated proteins, miRNA,
speciﬁc substrates, cofactors, enzymes participating in the bio-
chemical reactions connected with epigenomics processes
could be biomarkers for detecting some metabolic diseases
(Casadesus and Low, 2006; Martens et al., 2009; Qureshi
et al., 2010).
1.1. Epigenetic modiﬁcations induced by microbial invasion
Several studies have shown that certain infectious agents (Hel-
icobacter pylori, Streptococcus bovis, Chlamydia pneumoniae,
Campylobacter rectus, Epstein-Barr virus, hepatitis viruses,
Human papilloma virus, polyomaviruses, etc.) can contributeMethylation of cytosine residues is associated with gene silencing.
s involved in the silencing. Alterations in methylation can also be
r-methylated heterochromatin and an actively transcribed tumor
ated in red).
Table 1 Examples of few microbe-induced epigenetic dysregulations.
Microbe Mode of action Eﬀects
Campylobacter rectus Methylation of igf2 promoter region Silencing of Igf2 P0 promoter by CpG
methylation in the placenta
Helicobacter pylori Polycomb-repressive marks pinpoint the promoters to be silenced Silencing of selected promoters by CpG
methylation
Epstein-Barr virus Up-regulation of DNMT1, 3A, 3B via the JNK-AP-1 pathway Silencing of E-cadherin promoter
Human adenovirus Stimulation of E2F activity, up-regulation of DNMT1; association
with DNMT1, stimulation of DNMT1 activity
Dysregulation of DNMT1, 3A, 3B
Human papillomavirus Association with DNMT1, stimulation of DNMT1 activity; increasing
histone acetylation
Activation of E2F and CDC25A promoters
Hepatitis B virus Up-regulation of DNMT1 via the cyclin D1-CDK4/6-pRb-E2F1
and p38MAPK pathways; up-regulation of DNMT3A1 and DNMT3A2;
Down-regulation of DNMT3B
Silencing of tumor suppressor genes
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gression of some diseases, especially in malignancies. Few
examples of microbe induced host gene methylations are in Ta-
ble 1. The symbiotic microorganisms have been implicated in
epigenetic thermotolerance variation of coral reef cnidarian
symbiosis, pea aphids, and cactuses (Gilbert et al., 2010). A
role of mammalian gut microbiota, as epigenetic modifying
factor, in the pathogenesis of metabolic syndrome and associ-
ated diseases has been meant (Dumas et al., 2006). Thus, the
different biotic and abiotic signals can produce changes in gene
expression that can persist after the effect has ceased (Oka
et al., 2011, Paschos and Allday, 2010). However, the epige-
nomic reprograming and post-translated molecular mecha-
nisms connected with symbiotic microﬂora remain unclear.
Through the analysis of different microbial molecules, the role
of gut indigenous microbiota in epigenomic mechanisms and
the consequences of gut micro ecological imbalance and epige-
netic abnormalities in the onset and progression of diseases are
associated (Murata et al., 2007; Alvarez-Venegas et al., 2007).
Microbial manipulation of host epigenetic marks as obli-
gate intracellular parasites has helped develop numerous ways
of hijacking cell processes to facilitate the completion of their
life cycle and sometimes to evade the immune responses of
their host. Microbes that cause persistent infections are likely
to beneﬁt from heritable epigenetic changes in host transcrip-
tion that produce an environment for their latent or persistent
state without having to continuously express the initiating
effectors (Virgin et al., 2009). Host genes involved in cell cycle
progression, senescence, survival, inﬂammation and immunity
are prime candidates as targets for such epigenetic control.
Some chronic bacterial infections are also associated with
malignancy, the most and widely studied being Helicobacter
pylori infection of human gastric mucosa. Moreover, many mi-
crobes have evolved ways of eluding the immune response and,
again, epigenetic changes in host cells have been implicated in
these processes. Viral infection can deregulate patterns of
repressive histone modiﬁcations that could then precipitate
aberrant DNA methylation and the reprograming of infected
cells and their progeny. This can engage the repression of tu-
mor suppressor genes, for which there will be a strong selection
in the development in cancer. Infection by diverse microbes ap-
pears to induce expression of DNA methyl transferases
(DNMTs) and/or polycomb group (PcG) proteins such as
EZH2. The important caveat is that the expression of DNMTs
and EZH2 correlates with cell proliferation rate; therefore ahigh level of expression might be a consequence of the pro-
portion of cells proliferating in tumors and/or chronically in-
ﬂamed tissue (Murata et al., 2007; Alvarez-Venegas et al.,
2007). The ﬁrst step in any epigenetic study is global DNA
methylation analyses which allow the detection and identiﬁ-
cation of DNA methylation. These approaches do not require
previous knowledge of the genome of reference, and most
rely on a prior enzymatic/chemical hydrolysis of DNA to ob-
tain 20-deoxymononucleosides, followed by the subsequent
separation by chromatographic means such as High Perfor-
mance Liquid Chromatography (HPLC) (Eick et al., 1983)
or High Performance Capillary Electrophoresis (HPCE) (Fra-
ga et al., 2000), and a ﬁnal detection step by UV spectros-
copy or mass spectrometry. Alternatively, the global
content of DNA methylation can also be quantiﬁed by enzy-
matic approaches such as the Luminometric Methylation As-
say (LUMA) (Karimi et al., 2006). DNA methylation refers
to the addition of a methyl group to the cytosine bases of
DNA to form 5-methylcytosine. DNA methylation occurs
in both prokaryotes and eukaryotes. In bacteria, DNA meth-
ylation differentiates the genome DNA from invading phage
DNA, so that phage DNA is cleaved by the host restriction
enzymes (Chinnusamy and Zhu, 2009).
Most epigenetic systems known in bacteria use DNA meth-
ylation as a signal that regulates a speciﬁc DNA–protein inter-
action. These systems are usually composed of a DNA
methylase and a DNA binding protein(s) that bind to DNA se-
quences overlapping the target methylation site, blocking
methylation of that site. Methylation of the target site, in turn,
inhibits protein binding, resulting in two alternative methyla-
tion states of the target site, methylated and non methylated.
The epigenetic modiﬁcations induced by infecting bacteria in
multicellular eukaryotes seem to be mediated by mechanisms
unrelated to the transfer of bacterial restriction-modiﬁcation
systems, and represent a novel research ﬁeld to be explored.
Some studies described that Campylobacter rectus, involved
in periodontal infections and associated with an increased risk
of pre-term births due to placental and fetal infection in hu-
mans, could induce, in infected mice, hyper-methylation in
the promoter region P0 of the Igf2 (insulin-like growth factor
2) gene in the placenta (Berger et al., 2009; Meissner, 2010),
and concluded that the intra-uterine growth restriction they
observed in Campylobacter rectus infected animals was a con-
sequence of the epigenetic alteration induced by the bacterial
infection in the murine placenta.
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In the past, the term ‘‘epigenetics’’ has been used to describe
the differentiation of genetically identical cells into distinct cell
types to form tissues and organs during development of a mul-
ticellular organism. In current practice the word is used by
biologists to describe heritable changes in gene expression that
occur without changes in the DNA sequence. In the strict
sense, epigenetic systems involve two or more heritable states,
each maintained by a positive feedback loop. In a broader
sense, however, any additional information superimposed to
the DNA sequence (e.g., methylation of DNA) can be consid-
ered ‘‘epigenetic (Josep and David, 2006). Pathogen-induced
alterations of host physiology, morphology, and behavior are
widely documented in the scientiﬁc literature. Perhaps the
most fascinating examples of these changes are those that have
been shown to be the result of a manipulative strategy of the
pathogen aimed at maximizing its survival and transmission.
In the last few years, however, evidence has accumulated that
histone modiﬁcations and chromatin remodeling regulate gene
expression and are thus key targets for pathogen manipulation
during an infection (Hamon and Cossart, 2008). One such
obvious target is host’s immune system. In recent years, the
epigenetic modulation of host’s transcriptional program linked
to host defense genes has emerged as a relatively common
occurrence of pathogenic viral and bacterial infections (Pas-
chos and Allday, 2010). Bacteria are the hallmark of epigenetic
studies on microbes and provide several pioneer examples on
infection-induced host gene reprogramming (Bhavsar et al.,
2007).
2. Conclusion
The regulation of complex eukaryote genomes entails not only
sequence-speciﬁc DNA-binding factors, but also additional
levels of regulation such as DNA modiﬁcations, histone
post-translational modiﬁcations and chromatin remodeling.
These modiﬁcations are often referred to as being epigenetic
although some of them have not been shown to fulﬁll the strict
deﬁnition of epigenetics, which implies heritability through
mitosis or meiosis (Berger et al., 2009). During development
and cellular differentiation, these epigenetic marks undergo
dynamic changes that ultimately contribute to produce and
maintain distinct cell types of an organism (Meissner, 2010).
Elucidating how these epigenetic marks participate in the reg-
ulation of cellular identity is crucial to better understand
embryonic development and etiology of many diseases. The
ability of microbes to epigenetically inﬂuence host gene expres-
sion plays a major role in the pathogenesis of chronic diseases.
Similarly, although the mechanisms are less well understood,
the idea of epigenetic changes in hostcells associated with
chronic microbial infections (e.g.H. pylori) contributing to dis-
ease is conceptually satisfying. What is less obvious is the sig-
niﬁcance of such heritable changes in host cell behavior during
acute pathogen mediated disease. Perhaps a unifying theme is
the modulation of the immune response, inﬂammation and
intracellular host defenses. This requires further exploration.
Although a lot of research has been done in the ﬁeld of epige-
netics, there remain active challenges and questions to be
answered.Acknowledgement
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